Biomea Fusion, Inc. (BMEA) stock

BMEANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30

$0.56−0.05 (-7.89%)

Close on Nov 12, 2026Market cap $40.79MP/E –Yield –

Biomea Fusion gross margin

Gross margin is gross profit as a percentage of revenue.

Biomea Fusion has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?